CJC-1295 with DAC 5mg Lyophilized – Long-Acting GHRH Analogue

$90.00

CJC-1295 with DAC 5mg is a long-acting GHRH analogue featuring Drug Affinity Complex technology for extended half-life. Lyophilized research vials, HPLC verified ≥98% purity.

6 in stock

Volume pricing
Quantity Unit price Save
1 – 3 $90.00 —
4+ $75.00 17%

Tier applies automatically at checkout.

Description

CJC-1295 with DAC 5mg – Extended Half-Life GHRH Analogue

CJC-1295 with DAC (Drug Affinity Complex) is a tetrasubstituted 30-amino acid GHRH analogue. The DAC component covalently binds to albumin in the bloodstream, dramatically extending its half-life compared to standard CJC-1295. This makes it ideal for studying prolonged GH secretion patterns in research models. Each vial contains 5mg lyophilized CJC-1295 with DAC.

Product Details

  • Quantity: 5mg per vial
  • Form: Lyophilized powder
  • Purity: ≥98% (HPLC verified)
  • Molecular Weight: ~3,647 Da
  • Storage: -20°C; stable 24+ months lyophilized

Research Applications

CJC-1295 DAC is widely studied in GH pulse research, anti-aging biology, sleep studies, and metabolism research requiring sustained GHRH activity.

For research purposes only. Not for human or veterinary use.

Reviews

There are no reviews yet.

Be the first to review “CJC-1295 with DAC 5mg Lyophilized – Long-Acting GHRH Analogue”

Your email address will not be published. Required fields are marked *

Research reference

A GHRH analogue bearing a Drug Affinity Complex (DAC) moiety that binds serum albumin, substantially extending circulating half-life relative to the non-DAC form. Used as a long-acting reference standard in GHRH pathway studies.

Class
Long-acting GHRH analogue
CAS
863288-34-0
Formula
C165H269N47O46
Storage
Lyophilized: -20°C. Reconstituted: 2-8°C.

Research use only. Sold as a chemical reference standard for in-vitro laboratory research. Not for human or veterinary use, and not a drug, food or cosmetic.